Your session is about to expire
← Back to Search
Precision Feedback for Anesthesia Care
N/A
Waitlist Available
Led By Zach Landis-Lewis
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participation in the Multicenter Perioperative Outcomes Group (MPOG) provider feedback email program.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights
Study Summary
This trial tests an improved feedback system for anesthesia providers to see if it increases care quality and engagement. Standard feedback emails are sent to the control group for comparison.
Who is the study for?
This trial is for anesthesia providers who are already part of the MPOG provider feedback email program. It's designed to see if a more personalized feedback method can improve their performance in providing care.Check my eligibility
What is being tested?
The study compares two types of email messages: precision-enhanced feedback emails with tailored content and visuals, versus standard 'one size fits most' audit and feedback emails currently used.See study design
What are the potential side effects?
There aren't any direct medical side effects since this isn't a drug or medical treatment trial. However, it will look into any unintended consequences on how providers work as a result of the different types of feedback.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Measure success rate (M) for operative cases of anesthesia care providers
Secondary outcome measures
Average dashboard login rate (L)
Average email click-through rate (CTR)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: precision-enhanced feedback email messagesExperimental Treatment1 Intervention
Providers receive an enhanced monthly email containing precision audit and feedback (A&F).
Group II: standard feedback email messagesActive Control1 Intervention
Providers receive the standard "one size fits most" A&F monthly email.
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,795 Previous Clinical Trials
6,370,436 Total Patients Enrolled
National Library of Medicine (NLM)NIH
39 Previous Clinical Trials
103,983 Total Patients Enrolled
Zach Landis-LewisPrincipal InvestigatorUniversity of Michigan
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: precision-enhanced feedback email messages
- Group 2: standard feedback email messages
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still availability for people to join this clinical trial?
"The information on clinicaltrials.gov suggests that this trial has ceased patient recruitment, having first been posted in March 2024 and last edited June 2023. Nonetheless, there are currently 1 other medical studies seeking participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger